资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医迅达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
map
#食管腺#
40篇内容 | 896人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=3488101119e7, topicName=食管腺, introduction=食管腺, content=null, image=null, comments=40, allHits=896, url=https://h5.medsci.cn/topic?id=101119, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102839, tagList=[TagDto(tagId=102839, tagName=食管腺)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1821027, encodeId=f6be182102eb9, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=北京友谊医院揭示:慢性胃食管反流病诱发食管腺癌的新机制, objectType=article, longId=731563, objectId=064ee31563bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064ee31563bc, replyNumber=0, likeNumber=62, createdTime=2022-08-20, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064ee31563bc, moduleTitle=北京友谊医院揭示:慢性胃食管反流病诱发食管腺癌的新机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=064ee31563bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821026, encodeId=cbb81821026e4, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=JAMA Oncol:伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌, objectType=article, longId=730595, objectId=f470e305957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f470e305957c, replyNumber=0, likeNumber=86, createdTime=2023-05-05, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f470e305957c, moduleTitle=JAMA Oncol:伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f470e305957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821024, encodeId=f1fb182102426, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=J Clin Oncol:PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂(ICI)的疗效, objectType=article, longId=221539, objectId=ea642215396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea642215396a, replyNumber=0, likeNumber=54, createdTime=2022-07-06, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea642215396a, moduleTitle=J Clin Oncol:PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂(ICI)的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ea642215396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821023, encodeId=239d1821023b2, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Br J Cancer:人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, objectType=article, longId=219398, objectId=db08219398f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db08219398f4, replyNumber=0, likeNumber=83, createdTime=2022-03-26, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db08219398f4, moduleTitle=Br J Cancer:人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=db08219398f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821019, encodeId=71c918210190d, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=AJG:人体中性激素的异常与胃癌和结肠直肠癌有关,而与食管腺癌无关, objectType=article, longId=208484, objectId=c888208484d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c888208484d5, replyNumber=0, likeNumber=120, createdTime=2021-11-29, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c888208484d5, moduleTitle=AJG:人体中性激素的异常与胃癌和结肠直肠癌有关,而与食管腺癌无关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c888208484d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821021, encodeId=d4ea1821021a8, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Lancet:纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, objectType=article, longId=212478, objectId=90e32124e8db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e32124e8db, replyNumber=0, likeNumber=65, createdTime=2021-07-22, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e32124e8db, moduleTitle=Lancet:纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90e32124e8db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821025, encodeId=582a1821025c6, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=治疗胃食管腺癌达到90.9%疾病控制率,Zymeworks HER2靶向双特异性抗体显“奇效”, objectType=article, longId=259632, objectId=614325963215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=614325963215, replyNumber=0, likeNumber=132, createdTime=2022-07-29, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=614325963215, moduleTitle=治疗胃食管腺癌达到90.9%疾病控制率,Zymeworks HER2靶向双特异性抗体显“奇效”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=614325963215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821022, encodeId=6c851821022ec, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Eur J Cancer:奥沙利铂/卡培他滨联合放疗(OxCapRT)对比紫杉醇/卡铂联合放疗(CarPacRT)新辅助治疗对可切除食管腺癌的疗效和安全性:NeoSCOPE长期随访结果, objectType=article, longId=213266, objectId=96fd2132664f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fd2132664f, replyNumber=0, likeNumber=73, createdTime=2022-01-25, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fd2132664f, moduleTitle=Eur J Cancer:奥沙利铂/卡培他滨联合放疗(OxCapRT)对比紫杉醇/卡铂联合放疗(CarPacRT)新辅助治疗对可切除食管腺癌的疗效和安全性:NeoSCOPE长期随访结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=96fd2132664f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821018, encodeId=6a07182101801, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, objectType=article, longId=205972, objectId=009f2059e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009f2059e2f7, replyNumber=0, likeNumber=78, createdTime=2021-10-12, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009f2059e2f7, moduleTitle=ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=009f2059e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821020, encodeId=1b7218210207b, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Br J Cancer:Mandard分级高:不代表食管腺癌对化疗无反应, objectType=article, longId=208932, objectId=7fa520893267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa520893267, replyNumber=0, likeNumber=72, createdTime=2021-06-01, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa520893267, moduleTitle=Br J Cancer:Mandard分级高:不代表食管腺癌对化疗无反应, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7fa520893267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821016, encodeId=2dc51821016db, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Lancet oncol:Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, objectType=article, longId=197540, objectId=9b6419e540b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6419e540b8, replyNumber=0, likeNumber=75, createdTime=2020-10-31, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6419e540b8, moduleTitle=Lancet oncol:Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9b6419e540b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821017, encodeId=cce1182101e37, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系, objectType=article, longId=203046, objectId=a13420304628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13420304628, replyNumber=0, likeNumber=51, createdTime=2021-03-26, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13420304628, moduleTitle=Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a13420304628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821014, encodeId=6cd41821014ae, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=AJG:男性循环性激素水平和食管腺癌风险, objectType=article, longId=186864, objectId=2adb186864ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2adb186864ff, replyNumber=0, likeNumber=61, createdTime=2020-07-05, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2adb186864ff, moduleTitle=AJG:男性循环性激素水平和食管腺癌风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2adb186864ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821015, encodeId=4a4b1821015d7, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Journal of Clinical Oncology:Bemarituzumab治疗晚期胃食管腺癌的I期研究, objectType=article, longId=190022, objectId=7727190022fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7727190022fc, replyNumber=0, likeNumber=109, createdTime=2020-09-04, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7727190022fc, moduleTitle=Journal of Clinical Oncology:Bemarituzumab治疗晚期胃食管腺癌的I期研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7727190022fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821013, encodeId=deb61821013b5, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clin Gastroenterology H:患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短, objectType=article, longId=176789, objectId=5a771e678937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a771e678937, replyNumber=0, likeNumber=74, createdTime=2019-10-27, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a771e678937, moduleTitle=Clin Gastroenterology H:患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5a771e678937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821012, encodeId=2d7f1821012a4, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=CLIN CANCER RES:胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系, objectType=article, longId=156407, objectId=993a15640e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993a15640e74, replyNumber=0, likeNumber=66, createdTime=2019-06-01, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993a15640e74, moduleTitle=CLIN CANCER RES:胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=993a15640e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821008, encodeId=546f182100892, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Gastroenterology:不同食管腺癌表型患者的预后差异, objectType=article, longId=147661, objectId=45de14e661f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45de14e661f9, replyNumber=0, likeNumber=84, createdTime=2019-03-23, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45de14e661f9, moduleTitle=Gastroenterology:不同食管腺癌表型患者的预后差异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45de14e661f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821010, encodeId=4bcb18210107c, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=JAMA Surg:胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素, objectType=article, longId=152352, objectId=680315235273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=680315235273, replyNumber=0, likeNumber=55, createdTime=2018-12-28, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=680315235273, moduleTitle=JAMA Surg:胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=680315235273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821009, encodeId=3d9f1821009ef, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clinical Gastroenterology H: 遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险, objectType=article, longId=149413, objectId=043c149413cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=043c149413cd, replyNumber=0, likeNumber=55, createdTime=2018-11-07, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=043c149413cd, moduleTitle=Clinical Gastroenterology H: 遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=043c149413cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821011, encodeId=6bec182101130, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=DDS: Barrett食管的早期诊断能改善食管腺癌的生存率, objectType=article, longId=153962, objectId=77e215396219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e215396219, replyNumber=0, likeNumber=65, createdTime=2018-12-08, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e215396219, moduleTitle=DDS: Barrett食管的早期诊断能改善食管腺癌的生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=77e215396219)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
食管腺
2020-05-29
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
北京友谊医院揭示:慢性胃食管反流病诱发食管腺癌的新机制
62
0
2022-08-20
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
JAMA Oncol:伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌
86
0
2023-05-05
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
J Clin Oncol:PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂(ICI)的疗效
54
0
2022-07-06
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Br J Cancer:人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险
83
0
2022-03-26
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
AJG:人体中性激素的异常与胃癌和结肠直肠癌有关,而与食管腺癌无关
120
0
2021-11-29
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Lancet:纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗
65
0
2021-07-22
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
治疗胃食管腺癌达到90.9%疾病控制率,Zymeworks HER2靶向双特异性抗体显“奇效”
132
0
2022-07-29
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Eur J Cancer:奥沙利铂/卡培他滨联合放疗(OxCapRT)对比紫杉醇/卡铂联合放疗(CarPacRT)新辅助治疗对可切除食管腺癌的疗效和安全性:NeoSCOPE长期随访结果
73
0
2022-01-25
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
ASCO GI 2020:Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性
78
0
2021-10-12
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Br J Cancer:Mandard分级高:不代表食管腺癌对化疗无反应
72
0
2021-06-01
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Lancet oncol:Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌
75
0
2020-10-31
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系
51
0
2021-03-26
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
AJG:男性循环性激素水平和食管腺癌风险
61
0
2020-07-05
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Journal of Clinical Oncology:Bemarituzumab治疗晚期胃食管腺癌的I期研究
109
0
2020-09-04
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Clin Gastroenterology H:患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短
74
0
2019-10-27
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
CLIN CANCER RES:胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系
66
0
2019-06-01
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Gastroenterology:不同食管腺癌表型患者的预后差异
84
0
2019-03-23
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
JAMA Surg:胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素
55
0
2018-12-28
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
Clinical Gastroenterology H: 遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险
55
0
2018-11-07
回复
yuhaisheng_ibp_32061711
(审核中...)
关注
已关注
前往app查看评论内容
#食管腺#
DDS: Barrett食管的早期诊断能改善食管腺癌的生存率
65
0
2018-12-08
回复
共40条
首页
上一页
下一页
尾页
页码:
1
/2页
20条/页
扫描二维码下载梅斯医学APP
map
科室
订阅+
更多科室
工具
服务
map
map